Osimertinib Impurity Standards, USP related compounds

Osimertinib is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor. Osimertinib is a medication used treat locally advanced or metastatic non-small-cell lung carcinomas (NSCLC) with specific mutations. Various Osimertinib related compounds or reference standards, listed on this page are needed in pharmaceutical research at the time to product development, ANDA filing or during production to study quality, stability, and genotoxicity study of Osimertinib related products. Synthink is a most trusted source of Osimertinib Degradation Impurities, Osimertinib Genotoxic impurities, Osimertinib Process Impurities, USP related compounds, Osimertinib impurities, N-Nitroso impurities etc. which are listed on this page.